ZA963389B - Isolating and culturing Schwann cells. - Google Patents

Isolating and culturing Schwann cells.

Info

Publication number: ZA963389B
Authority: ZA; South Africa
Prior art keywords: schwann cells; culturing; cells; culture medium; cell culture
Prior art date: 1995-05-10

Application number

ZA9603389A

Other languages

English (en)

Inventor

Jennie P Mather

Ronghao Li

Jian Chen

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-10

Filing date

1996-04-29

Publication date

1997-10-29

1996-04-29 Application filed by Genentech Inc filed Critical Genentech Inc

1997-10-29 Publication of ZA963389B publication Critical patent/ZA963389B/xx

Links

210000004116 schwann cell Anatomy 0.000 title abstract 6
238000012258 culturing Methods 0.000 title abstract 4
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 abstract 2
208000016192 Demyelinating disease Diseases 0.000 abstract 1
206010012305 Demyelination Diseases 0.000 abstract 1
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 abstract 1
208000001738 Nervous System Trauma Diseases 0.000 abstract 1
102000048238 Neuregulin-1 Human genes 0.000 abstract 1
108090000556 Neuregulin-1 Proteins 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
238000004113 cell culture Methods 0.000 abstract 1
239000006143 cell culture medium Substances 0.000 abstract 1
230000001413 cellular effect Effects 0.000 abstract 1
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000003226 mitogen Substances 0.000 abstract 1
210000000944 nerve tissue Anatomy 0.000 abstract 1
238000011533 pre-incubation Methods 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
239000004017 serum-free culture medium Substances 0.000 abstract 1
230000004083 survival effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/195—Heregulin, neu differentiation factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Developmental Biology & Embryology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Control Of Combustion (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Thermotherapy And Cooling Therapy Devices (AREA)

ZA9603389A 1995-05-10 1996-04-29 Isolating and culturing Schwann cells. ZA963389B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/438,863 US5849585A (en)	1995-05-10	1995-05-10	Isolating and culturing Schwann cells

Publications (1)

Publication Number	Publication Date
ZA963389B true ZA963389B (en)	1997-10-29

Family

ID=23742342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9603389A ZA963389B (en)	1995-05-10	1996-04-29	Isolating and culturing Schwann cells.

Country Status (11)

Country	Link
US (1)	US5849585A (de)
EP (1)	EP0826035B1 (de)
JP (1)	JP3410103B2 (de)
AT (1)	ATE320483T1 (de)
AU (1)	AU714177B2 (de)
CA (1)	CA2218909C (de)
DE (1)	DE69635924T2 (de)
IL (1)	IL118150A (de)
MX (1)	MX9708527A (de)
WO (1)	WO1996035776A1 (de)
ZA (1)	ZA963389B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL124005A (en) *	1995-11-01	2004-06-20	Genentech Inc	Normal neural epithelial precursor cells
IL124722A0 (en) *	1998-06-02	1999-01-26	Oron Amir	Ischemia laser treatment
US6214035B1 (en) *	1999-03-23	2001-04-10	Jackson Streeter	Method for improving cardiac microcirculation
EP1370134B1 (de) *	2001-03-23	2016-03-23	University Of Ottawa	Verfahren und zusammensetzungen zur kryokonservierung von dissoziirten primären tierzellen
JP3886346B2 (ja) *	2001-06-22	2007-02-28	サンバイオ，インコーポレイティド	骨髄間質細胞由来Ｓｃｈｗａｎｎ細胞を含む神経再生用医薬組成物
US7534255B1 (en)	2003-01-24	2009-05-19	Photothera, Inc	Low level light therapy for enhancement of neurologic function
US9993659B2 (en)	2001-11-01	2018-06-12	Pthera, Llc	Low level light therapy for enhancement of neurologic function by altering axonal transport rate
US10683494B2 (en)	2001-11-01	2020-06-16	Pthera LLC	Enhanced stem cell therapy and stem cell production through the administration of low level light energy
US7303578B2 (en)	2001-11-01	2007-12-04	Photothera, Inc.	Device and method for providing phototherapy to the brain
US8308784B2 (en)	2006-08-24	2012-11-13	Jackson Streeter	Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US10695577B2 (en)	2001-12-21	2020-06-30	Photothera, Inc.	Device and method for providing phototherapy to the heart
US7316922B2 (en)	2002-01-09	2008-01-08	Photothera Inc.	Method for preserving organs for transplant
IL163547A0 (en) *	2002-02-12	2005-12-18	Quark Biotech Inc	Use of the axl receptor for diagnosis and treatment of renal disease
AU2003247514A1 (en) *	2002-06-11	2003-12-22	Roy Ogle	Meningeal-derived stem cells
JP2007508816A (ja) *	2003-10-10	2007-04-12	ゲ・ミン・ルイ	細胞培養および組織培養プラットフォームのための組成物および方法
CA2545553A1 (en) *	2003-11-21	2005-06-09	Arena Pharmaceuticals, Inc.	Methods for producing olfactory gpcrs
TWI276685B (en) *	2003-12-30	2007-03-21	Ind Tech Res Inst	Conditional medium for culturing Schwann cells
US20070004036A1 (en) *	2005-07-01	2007-01-04	Rodolfo Faudoa	Methods and compositions for keratinocyte culture
US20070128685A1 (en) *	2005-07-01	2007-06-07	Rodolfo Faudoa	Methods and compositions for cell culture
US20070003541A1 (en) *	2005-07-01	2007-01-04	Rodolfo Faudoa	Methods and compositions for therapeutics
US20090254154A1 (en)	2008-03-18	2009-10-08	Luis De Taboada	Method and apparatus for irradiating a surface with pulsed light
US7575589B2 (en)	2006-01-30	2009-08-18	Photothera, Inc.	Light-emitting device and method for providing phototherapy to the brain
US10357662B2 (en)	2009-02-19	2019-07-23	Pthera LLC	Apparatus and method for irradiating a surface with light
US7848035B2 (en)	2008-09-18	2010-12-07	Photothera, Inc.	Single-use lens assembly

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4443546A (en) *	1980-07-07	1984-04-17	The Beth Israel Hospital Association	Process and composition for propagating mammalian cells
NZ206699A (en) *	1982-12-30	1989-08-29	Bio Response Inc	Process for the production of serum independent cell lines
US4662884A (en) *	1984-04-25	1987-05-05	University Of Utah Research Foundation	Prostheses and methods for promoting nerve regeneration
US5030225A (en) *	1987-03-13	1991-07-09	Brown University Research Foundation	Electrically-charged nerve guidance channels
AU621972B2 (en) *	1988-12-14	1992-03-26	United States of America, as represented by the Secretary, U.S. Department of Commerce, The	Cell culture medium for human liver epithelial cell line
US5082670A (en) *	1988-12-15	1992-01-21	The Regents Of The University Of California	Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
CA2089582A1 (en) *	1990-08-15	1992-02-16	Richard P. Bunge	Autotransplantation of schwann cells to promote nervous system repair
JPH0789908B2 (ja) *	1991-02-28	1995-10-04	倉敷紡績株式会社	動物細胞培養用無血清培地
US5530109A (en) *	1991-04-10	1996-06-25	Ludwig Institute For Cancer Research	DNA encoding glial mitogenic factors
GB9107566D0 (en) *	1991-04-10	1991-05-29	Ludwig Inst Cancer Res	Glial mitogenic factors,their preparation and use
EP0615452A4 (de) *	1991-11-25	1995-07-12	Inst Molecular Biology Inc	Medikament zur unterstützung des wachstums von nerven in säugetieren.
GB9217316D0 (en) *	1992-08-14	1992-09-30	Ludwig Inst Cancer Res	Schwann cell mitogenic factor,its preparation and use

1995
- 1995-05-10 US US08/438,863 patent/US5849585A/en not_active Expired - Lifetime
1996
- 1996-04-26 CA CA2218909A patent/CA2218909C/en not_active Expired - Fee Related
- 1996-04-26 DE DE69635924T patent/DE69635924T2/de not_active Expired - Lifetime
- 1996-04-26 MX MX9708527A patent/MX9708527A/es not_active IP Right Cessation
- 1996-04-26 AU AU55789/96A patent/AU714177B2/en not_active Ceased
- 1996-04-26 WO PCT/US1996/005846 patent/WO1996035776A1/en not_active Ceased
- 1996-04-26 AT AT96913200T patent/ATE320483T1/de active
- 1996-04-26 EP EP96913200A patent/EP0826035B1/de not_active Expired - Lifetime
- 1996-04-26 JP JP53410196A patent/JP3410103B2/ja not_active Expired - Lifetime
- 1996-04-29 ZA ZA9603389A patent/ZA963389B/xx unknown
- 1996-05-05 IL IL11815096A patent/IL118150A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69635924D1 (de)	2006-05-11
IL118150A0 (en)	1996-09-12
MX9708527A (es)	1998-02-28
DE69635924T2 (de)	2006-12-14
AU5578996A (en)	1996-11-29
AU714177B2 (en)	1999-12-23
JP3410103B2 (ja)	2003-05-26
ATE320483T1 (de)	2006-04-15
US5849585A (en)	1998-12-15
WO1996035776A1 (en)	1996-11-14
JPH10507081A (ja)	1998-07-14
IL118150A (en)	2000-08-31
EP0826035A1 (de)	1998-03-04
CA2218909C (en)	2010-06-29
CA2218909A1 (en)	1996-11-14
EP0826035B1 (de)	2006-03-15

Publication	Publication Date	Title
IL118150A0 (en)	1996-09-12	Isolating and culturing schwann cells
AU8476698A (en)	1999-01-25	Human mesenchymal stem cells from peripheral blood
IL210618A (en)	2015-06-30	Cell cultures containing isolated and multiplied human cells other than embryonic and germ cells, pharmaceutical preparations containing them, methods of preparation, and methods for identifying modulators and differentiation factors.
AU2782499A (en)	1999-09-15	Isolated stromal cells for use in the treatment of diseases of the central nervous system
ATE347585T1 (de)	2006-12-15	In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
WO2003072714A3 (en)	2006-12-28	Follistatin domain containing proteins
HUP0500477A2 (hu)	2005-08-29	Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával
PL320484A1 (en)	1997-09-29	Method of treating diabetes using kgf
PL325646A1 (en)	1998-08-03	Transplantation of nerve cells using pluripotential nuroepithelial cells
AU7506396A (en)	1997-05-29	Composition for improving pancreatic function
WO2002010350A1 (en)	2002-02-07	Method of proliferating natural killer cells
EP1405906A4 (de)	2008-03-19	Aus myeloiden interstitialzellen stammende schwann'sche zellen
WO1999029279A3 (en)	1999-10-21	Long-term survival and regeneration of central nervous system neurons
AU6314296A (en)	1997-02-05	Therapeutic agents and autoimmune diseases
WO2004011631A3 (en)	2004-04-08	Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
ATE268811T1 (de)	2004-06-15	Therapeutische anwendungen von chimänischer organogenese
AU2534595A (en)	1995-12-21	Angiotensin ii for improving fertilization
AU4037299A (en)	1999-11-29	Genetically-modified fibroblasts and the use thereof
WO2000052142A3 (en)	2001-03-22	Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation
WO2003038090A1 (fr)	2003-05-08	Procede d'induction de differentiation de cellules souches mesodermiques immortalisees dans les cellules du systeme nerveux
AU8478601A (en)	2002-02-18	Methods for culturing human lung mast cells and uses thereof
AU2182801A (en)	2001-06-12	Method for producing adherent animal cells
GR3031236T3 (en)	1999-12-31	Process for the preparation of pilocarpine.
MX9705612A (es)	1998-10-31	Induccion dirigida por linaje de la diferenciacion de celulas mesenquimatosas humanas de origen.
PL285546A1 (en)	1992-01-13	Biological culture medium for cell cultures and method of culturing human keratocytes as well as proteinous concentrate